NC3Rs
Overview
A UK-based scientific organisation established in 2004 that works to replace, refine, and reduce the use of animals in research and testing (the 3Rs). It collaborates with scientists and organizations across the life sciences sector by funding research, supporting early career development, fostering open innovation, and stimulating changes in policy and regulations.
Portfolio Companies
5
Website
nc3rs.org.ukInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Toxys | Dec 2024 | Grant | Co-investor |
| Actual Analytics | Jul 2013 | Grant | Co-investor |
| MIMETAS | Feb 2022 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NC3Rs based?
NC3Rs is headquartered in London, England, United Kingdom.
When was NC3Rs founded?
Founding year information for NC3Rs is not publicly available.
How many portfolio companies does NC3Rs have?
NC3Rs has 5 portfolio companies in Caplight's dataset.
What are some companies in NC3Rs's portfolio?
Portfolio companies visible on Caplight include Toxys, Actual Analytics, MIMETAS.
What was NC3Rs's most recent investment shown here?
NC3Rs's most recent investment in this portfolio sample was in Toxys in 2024.
What sectors does NC3Rs focus on?
NC3Rs focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech.
What company stages does NC3Rs focus on?
NC3Rs typically invests at the MultiStage stage.